Hydrogel encapsulations and methods of making the same
US-2024180220-A1 · Jun 6, 2024 · US
US10512796B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10512796-B2 |
| Application number | US-201013500937-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 30, 2010 |
| Priority date | Dec 31, 2009 |
| Publication date | Dec 24, 2019 |
| Grant date | Dec 24, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within a metal oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
Opening claim text (preview).
The invention claimed is: 1. A process for preparing microcapsules having a core encapsulated within a metal oxide shell, said process comprising: (a) preparing an oil-in-water emulsion by emulsification of an oily phase comprising at least one active agent and at least one phase changing material, in an aqueous phase, wherein at least one of said oily phase and aqueous phase comprise a sol-gel precursor; (b) subjecting said emulsion to microcapsule forming conditions; thereby obtaining said microcapsules; wherein said core comprises at least one active agent and at least one phase changing material and the core is surrounded by a metal oxide shell of said microcapsule; wherein said at least one phase changing material yields the core having a viscosity of between about 300 cP to 1,000,000 cP; wherein said at least one phase changing material is not liquid at room temperature. 2. The process according to claim 1 , wherein said at least one active agent is selected from a pharmaceutical agent, a cosmetic agent and a dermatological agent. 3. The process according to claim 1 , wherein said at least one active agent is a dermatological agent selected from anti-fungal agents, anti-bacterial agents, anti-inflammatory agents, anti-pruritic agents, anti-psoriatic agents, anti-acne agents, anti-rosacea agents, and any combinations thereof. 4. The process according to claim 1 , wherein said at least one active agent is an anti acne agent selected from benzoyl peroxide, retinoid, and mixtures thereof. 5. The process according to claim 1 , further comprising adding at least one nanoparticle of at least one metal oxide to said aqueous phase prior, during or after preparation of oil-in-water emulsion of step (a). 6. The process according to claim 1 , wherein said at least one phase changing material is selected from natural or synthetic paraffin, waxes, aliphatic alcohols, fatty acids or any combination thereof, wherein said fatty acids have a formula of CH 3 (CH 2 ) n COOH, and wherein n=10-100. 7. The process according to claim 1 , further comprising adding a metal oxide salt to said aqueous phase prior, during or after emulsification of step (a). 8. The process according to claim 1 , wherein said oily phase comprises a sol-gel precursor. 9. The process according to claim 1 , wherein the pH of said aqueous phase is in the range of between about 2 to about 9.
Antimycotics · CPC title
Antibacterial agents · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Anti-acne agents · CPC title
Antiseborrheics · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.